Pushkal Garg insider trades
Open-market stock purchases and sales by Pushkal Garg, EVP Chief R&D at Alnylam Pharmaceuticals, Inc, from SEC Form 4 filings since Oct 29, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 5, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $211K |
| Mar 5, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $239K |
| Mar 5, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $166K |
| Mar 5, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $163K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $33.8K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $32.6K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $69K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $93K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $113K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $248K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $88.4K |
| Mar 4, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $67.7K |
| Mar 3, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $112K |
| Mar 3, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $101K |
| Mar 3, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $205K |
| Mar 3, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $149K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $16.2K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $31.5K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $90.2K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $35.2K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $60K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $28.8K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $33.5K |
| Mar 2, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Sold | $14K |